The Centre for Medicines Discovery aims to catalyse the discovery
and development of new medicines for patients.
News
ASAP Discovery Consortium wins 2023 FASEB Dataworks prize
9 February 2024
Publications
-
Type I interferon regulation by USP18 is a key vulnerability in cancer
Journal article
Jové V. et al, (2024), iScience, 27
-
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist.
Journal article
Balıkçı E. et al, (2024), J Med Chem
-
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.
Journal article
Hamid MHBA. et al, (2024), Nat Immunol